Loading organizations...
Key people at Chemical Angel Network.
Chemical Angel Network was founded in 2012 by Sid White (Co-founder) and Judy Giordan (Co-Founder) and Mark Vreeke (Co-founder).
The Chemical Angel Network (CAN) connects accredited angel investors with early-stage chemical and materials science companies. It sources, evaluates, and syndicates opportunities, offering financial capital and experienced mentorship. CAN utilizes a structured, virtual monthly cycle for vetting proposals, and its CAN Fund I invests directly in startups focused on chemistry and material innovations.
Co-founded in 2012 by Mark Vreeke, Sid White, and Judith Giordan, the network originated from their American Chemical Society connections. Their insight was creating a specialized nationwide angel investing platform for early-stage chemical businesses. Their experience in chemistry and venture development uniquely positioned them to foster innovation.
CAN serves accredited angel investors and entrepreneurs leading seed-stage chemical companies. Its mission provides capital, mentorship, contacts, and technical expertise. The network’s vision aims to accelerate the growth of chemistry-enabled businesses, fostering innovation and bringing new material technologies to market.
Key people at Chemical Angel Network.
Chemical Angel Network was founded in 2012 by Sid White (Co-founder) and Judy Giordan (Co-Founder) and Mark Vreeke (Co-founder).
The Chemical Angel Network (CAN) is an angel investment network dedicated to connecting accredited investors with early-stage chemical companies, providing both financial capital and experienced mentorship to foster innovation in the chemical economy.[1][2][3] Its mission is to source, evaluate, and syndicate quality seed-stage opportunities nationwide through a virtual, monthly process, while stimulating growth in chemistry and materials-focused startups; it recently closed its inaugural CAN Fund I in 2022 to deploy into such ventures.[1][4] CAN's investment philosophy emphasizes shared due diligence, technical expertise, and networking among qualified investors, targeting disruptive technologies in chemistry-related innovations to drive high-return potential and portfolio success.[2][5]
By offering a streamlined platform for pitches, CAN impacts the startup ecosystem by reducing vetting friction for entrepreneurs, pooling resources from chemistry-savvy angels, and bridging gaps in early funding for specialized sectors often overlooked by generalist VCs.[1][2][6]
Founded to address the need for targeted funding in chemical startups, the Chemical Angel Network emerged as a platform uniting experienced professionals in the field, though exact founding year details are not specified in available sources.[1][2] Key partners include a network of highly qualified accredited investors—often senior chemists and industry experts—who contribute technical know-how, with operations based in Aliso Viejo, California.[2][3] The network's evolution includes launching CAN Fund I's first close in August 2022 as the start of a series of member-led funds, shifting toward structured syndication; it has since added quarterly newsletters (from 2024) and the "Activation Energy" podcast to engage investors and entrepreneurs on chemical industry challenges.[1][4]
This progression reflects a focus on virtual efficiency, shared expertise, and expanding reach to nationwide early-stage chemical ventures.[1][2]
CAN rides the wave of chemistry and materials innovation critical for addressing global health and environmental challenges, such as sustainable materials and biotech advancements, where specialized early-stage funding is scarce.[1][3][5] Timing aligns with rising demand for chemical economy growth amid climate tech and advanced manufacturing booms, positioning CAN to capitalize on untapped intellectual capital from senior chemists.[2] Market forces like increasing VC interest in deep tech but hesitation in niche chemical risks favor CAN's expert network, which de-risks deals through domain-specific vetting.[6] It influences the ecosystem by stimulating startup formation, enabling syndication at seed stage, and fostering mentorship that accelerates technical milestones in an industry pivotal to net-zero transitions.[1][2][5]
CAN is poised to expand its fund series beyond CAN Fund I, scaling investments into chemistry disruptors amid surging demand for materials science in clean energy and health tech.[1][4][5] Trends like AI-driven molecule discovery and regulatory pushes for sustainable chemicals will amplify its role, potentially growing membership and deal flow through virtual tools and content like podcasts.[1] Its influence may evolve toward larger syndicates or sector-specific accelerators, solidifying CAN as a cornerstone for chemical startup funding and returning to its core promise of fueling the chemical economy's next wave.[2][3]
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 10, 2023 | CARI Health | $2.3M Seed | Mysty Rusk | Chemical Angel Fund, Cove Fund, Device of Tomorrow Capital, NuFund Venture Group |
| Sep 26, 2019 | Zylö Therapeutics | $4.0M Series A | VentureSouth | Ariel Southeast Angel Partners, Boston Harbor Angels, Chemical Angel Fund, New York Angels, SCRA Technology Ventures |